FIG 6.

Growth/survival of hvKP1 and hvKP1 ΔiucA in human ascites fluid supplemented with purified aerobactin or conditioned medium generated by hvKP1 or hvKP1 ΔiucA. The growth/survival of hvKP1 and hvKP1 ΔiucA was assessed at 0, 3, 6, and 24 h in 100% human ascites fluid. (A) Growth/survival of hvKP1 in ascites fluid that was not supplemented (0%) or was supplemented with 10% conditioned ascites fluid generated by hvKP1 (aerobactin replete) or hvKP1 ΔiucA (aerobactin deficient) or purified aerobactin (460 nM; 260 μg/ml). *, P < 0.05/3. (B) Growth/survival of hvKP1 ΔiucA in ascites fluid that was not supplemented (0%) or was supplemented with 10% of conditioned ascites fluid generated by hvKP1 (aerobactin replete) or hvKP1 ΔiucA (aerobactin deficient) or purified aerobactin (460 nM; 260 μg/ml). *, P < 0.05/3. Data are means ± SEM; n = 4 to 6.